KUMIAI CHEMICAL INDUSTRY CO., LTD. (4996) Stock Price

Market cap
¥101.1B
P/E ratio
14.3x
Kumiiai Chemical Industries makes pesticides and agricultural chemicals for farmers, primarily selling through Japan's agricultural cooperative network.

Price and Volume

Market Cap

Subscribe to premium to access
Market Cap.

Check pricing

PER

Subscribe to premium to access
PER.

Check pricing

PBR

Business Overview

Kumiiai Chemical Industries is a chemical manufacturer with agrochemicals as its core business. The company manufactures insecticides, fungicides, herbicides, and other products. Domestically, it sells to farmers through the National Federation of Agricultural Cooperative Associations, while non-agricultural applications such as golf course treatments are supplied through group companies.

The center of revenue is agrochemical sales for domestic agriculture, with the national agricultural cooperative network serving as the primary customer channel. The company sources some raw materials from within its group and overseas, and sells products in Asia, the United States, and other regions through overseas subsidiaries and international sales divisions.

Operations are divided into three main segments: agrochemicals and agriculture-related business, chemical products business, and other business. In chemical products, the company handles basic chemicals such as chlorotoluene and chloroxylene derivatives, as well as fine chemicals including pharmaceutical intermediates and resin raw materials, and industrial chemicals for environmental sanitation and medical applications. The company also engages in expanded polystyrene manufacturing, real estate leasing, power generation and sales, with group companies handling manufacturing, sales, logistics, construction, and human resources functions.

Management Policy

The company is pursuing enhanced profitability and sustainable growth based on its medium-term management plan "KUMI STORY 2026." Specific targets for the fiscal year ending October 2026 include net sales of 185,000 million yen, operating profit of 16,000 million yen, and return on equity (ROE) of 11.0% or higher. The company aims to strengthen its earnings foundation by optimizing resource allocation with R&D at its core and enhancing coordination across production, logistics, and sales.

Priority investment areas are pesticide R&D and higher-value chemical products. Beyond conventional chemical pesticides, the company is investing in microbial pesticides and bio-based products. Differentiation strategies include functional differentiation through new combination formulations and reformulations of core products (such as Effidia, Axive, and Dizalta), intellectual property protection including litigation when necessary, and cost reduction through optimized active ingredient manufacturing and supplier negotiations. The goal is to simultaneously strengthen price competitiveness and market uniqueness.

The company is also focusing on overseas and new market development, including expanded sales of Effidia and Dizalta in Korea, the Americas, and Asia; new combination formulation rollout of Axive in the United States; and initial overseas evaluation of the microbial pesticide Ecoark. Additionally, the company aims to diversify its business scope and expand sales and profits through increased non-agricultural demand (such as golf courses) and contract manufacturing, as well as expansion into semiconductor and electronic materials from its chemical products division.

On the innovation front, the company continuously pursues new active ingredient development and product improvements, with concrete pipelines including registration applications for the new acaricide Banenta and market launch preparations for the microbial pesticide Ecoark (scheduled for registration in March 2025). The company is also addressing environmental concerns, targeting a 30% reduction in greenhouse gas emissions by fiscal 2030 compared to fiscal 2019 levels and aiming for carbon neutrality by 2048 through CO2-free power adoption. By combining R&D, production, human resources (new HR system scheduled for November 2025), and digital transformation, the company seeks to strengthen competitiveness across both technology and organizational capabilities.

AI Chat